Form 8-K - Current report:
SEC Accession No. 0000950170-25-083746
Filing Date
2025-06-09
Accepted
2025-06-09 16:15:28
Documents
10
Period of Report
2025-06-05
Items
Item 5.07: Submission of Matters to a Vote of Security Holders

Document Format Files

Seq Description Document Type Size
1 8-K bioa-20250605.htm   iXBRL 8-K 53453
  Complete submission text file 0000950170-25-083746.txt   162628

Data Files

Seq Description Document Type Size
2 XBRL TAXONOMY EXTENSION SCHEMA WITH EMBEDDED LINKBASES DOCUMENT bioa-20250605.xsd EX-101.SCH 25813
12 EXTRACTED XBRL INSTANCE DOCUMENT bioa-20250605_htm.xml XML 4883
Mailing Address 5885 HOLLIS STREET SUITE 370 EMERYVILLE CA 94608
Business Address 5885 HOLLIS STREET SUITE 370 EMERYVILLE CA 94608 510-806-1445
BioAge Labs, Inc. (Filer) CIK: 0001709941 (see all company filings)

EIN.: 474721157 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-42279 | Film No.: 251034292
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)